Clinical Trial Update: A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo. [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial in South Africa evaluates maternal safety and infant protection against RSV lower respiratory tract infection when the pregnant woma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV vaccine (respiratory syncytial virus vaccine)

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: RSV Infections, RSV Immunisation | Phase 4 | Status: NOT_YET_RECRUITING